Nuclear factor-κB activity in T cells from patients with rheumatic diseases: A preliminary report. Issue 12 (1st December 1998)

• Record Type: Journal Article
• Authors: Collantes, Eduardo; Blázquez, M Valle; Mazorra, Vivian; Macho, Antonio; Aranda, Enrique; Muñoz, Eduardo
• Is Part Of: Annals of the rheumatic diseases. Volume 57:Issue 12(1998)
• Page Start: 738
• Page End: 741
• Publication Date: 1998-12-01
• Subjects: NF-κB -- synovial T cells -- rheumatoid arthritis -- spondyloarthropathy -- osteoarthritis; Rheumatism -- Periodicals; 616.723005
• DOI: 10.1136/ard.57.12.738
• Languages: English
• ISSNs: 0003-4967

Abstract

Abstract : OBJECTIVE: The NF-κB/Rel family of transcription factors regulates the expression of many genes involved in the immune or inflammatory response at the transcriptional level. The aim of this study was to determine whether distinctive patterns of NF-kB activation are seen in different forms of joint disease. METHODS: The DNA binding activity of these nucleoproteins was examined in purified synovial and peripheral T cells from patients with various chronic rheumatic diseases (12: four with rheumatoid arthritis; five with spondyloarthropathies; and three with osteoarthritis). RESULTS: Electrophoretic mobility shift assays disclosed two specific complexes bound to a NF-κB specific 32 P-labelled oligonucleotide in nucleoproteins extracted from purified T cells isolated from synovial fluid and peripheral blood of patients with rheumatoid arthritis. The complexes consisted of p50/p50 homodimers and p50/p65 heterodimers. Increased NF-kB binding to DNA in synovial T cells was observed relative to peripheral T cells. In non-rheumatoid arthritis, binding of NF-κB in synovial T cells was exclusively mediated by p50/p50 homodimers. CONCLUSION: Overall, the results suggest that NF-κB may play a central part in the activation of infiltrating T cells in chronic rheumatoid arthritis. The activation of this nuclear factor is qualitatively different in rheumatoid synovial T cells to that in other forms of non-rheumatoid arthritis (for example, osteoarthritis, spondyloarthropathies).